- News
- Fenebrutinib
Tag:
Fenebrutinib
-
Swiss drugmaker Roche said on Monday that its experimental multiple sclerosis (MS) treatment, fenebrutinib, has met the primary goal in a late-stage clinical trial.
10 Nov 2025-10:30 -